Arbutus Biopharma (ABUS) EBITDA Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,618.00 |
| Dec 31, 2025 | 17,986.00 |
| Sep 30, 2025 | -63,772.00 |
| Jun 30, 2025 | 88,182.00 |
| Mar 31, 2025 | -57,510.00 |
| Dec 31, 2024 | -7,636.00 |
| Sep 30, 2024 | 137,251.00 |
| Jun 30, 2024 | 191,110.00 |
| Mar 31, 2024 | 156,320.00 |
| Dec 31, 2023 | 4,010.00 |
| Sep 30, 2023 | 158,041.00 |
| Jun 30, 2023 | 137,690.00 |
| Mar 31, 2023 | 102,128.00 |
| Dec 31, 2022 | 201,634.00 |
| Sep 30, 2022 | -11,211.00 |
| Jun 30, 2022 | 177,629.00 |
| Mar 31, 2022 | 769,958.00 |
| Dec 31, 2021 | 13.14 Mn |
| Sep 30, 2021 | 190,041.00 |
| Jun 30, 2021 | 6.24 Mn |